摘要:
China unveiled a litany of bribery and misconduct allegations against GlaxoSmithKline GSK.LN -0.26% PLC, a move that industry experts said could presage a broader crackdown in a lucrative market for pharmaceutical and medical companies.a litany of:一连串 bribery:贿赂,行贿 misconduct:行为不检 presage:预... 阅读全文
posted @ 2013-07-16 21:11
微雪
阅读(411)
评论(0)
推荐(0)

浙公网安备 33010602011771号